The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 10, Pages 2539
Publisher
MDPI AG
Online
2019-05-24
DOI
10.3390/ijms20102539
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
- (2016) Henrik H. Hansen et al. BRAIN RESEARCH
- Type 2 Diabetes Mellitus and Alzheimer's Disease: Bridging the Pathophysiology and Management
- (2016) Fahmida Alam et al. CURRENT PHARMACEUTICAL DESIGN
- Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes
- (2016) Trevor Hardigan et al. LIFE SCIENCES
- Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease
- (2016) Jayasankar Kosaraju et al. MOLECULAR NEUROBIOLOGY
- DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice
- (2015) MingJie Ma et al. Cardiovascular Diabetology
- Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline
- (2015) V. A. Gault et al. DIABETES OBESITY & METABOLISM
- A Novel Mouse Model of Subcortical Infarcts with Dementia
- (2015) Y. Hattori et al. JOURNAL OF NEUROSCIENCE
- Cognitive function in patients with diabetes mellitus: guidance for daily care
- (2015) Paula S Koekkoek et al. LANCET NEUROLOGY
- A review on Alzheimer's disease pathophysiology and its management: an update
- (2015) Anil Kumar et al. Pharmacological Reports
- Aberrant insulin signaling in Alzheimer's disease: current knowledge
- (2015) Gaurav Bedse et al. Frontiers in Neuroscience
- The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
- (2014) Konrad Talbot et al. Alzheimers & Dementia
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- Insulin dysfunction and Tau pathology
- (2014) Noura B. El Khoury et al. Frontiers in Cellular Neuroscience
- Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
- (2014) Inês Sebastião et al. Frontiers in Endocrinology
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
- (2012) Swenja Kröller-Schön et al. CARDIOVASCULAR RESEARCH
- Lipid Sensing and Insulin Resistance in the Brain
- (2012) Jessica T.Y. Yue et al. Cell Metabolism
- Detrimental Effects of Diet-Induced Obesity on Pathology Are Independent of Insulin Resistance in Transgenic Mice
- (2012) A. Leboucher et al. DIABETES
- Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures
- (2012) Dong-Hou Kim et al. NEUROBIOLOGY OF DISEASE
- The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
- (2012) Caitriona M. Long-Smith et al. NEUROMOLECULAR MEDICINE
- Insulin resistance and Alzheimer's disease
- (2011) Suzanne M. De La Monte BMB Reports
- Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain
- (2011) A. Hamilton et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
- (2011) Amit Gupta et al. NEUROPHARMACOLOGY
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection
- (2010) Alexander Harkavyi et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search